Improved Genomic Assembly and Genomic Analyses of Entamoeba Histolytica

Total Page:16

File Type:pdf, Size:1020Kb

Improved Genomic Assembly and Genomic Analyses of Entamoeba Histolytica Improved genomic assembly and genomic analyses of Entamoeba histolytica Thesis submitted in accordance with the requirements of the University of Liverpool for the degree of Doctor in Philosophy by Amber Leckenby September 2018 Acknowledgements There are many people without whom this thesis would not have been possible. The list is long and I am truly grateful to each and every one. Firstly I have to thank my supervisors Gareth, Christiane, Neil and Steve for the continuous support throughout my PhD. Particularly, I am grateful to Gareth and Christiane, for their patience, motivation and immense knowledge that helped me through the entirety of the proJect from the initial research to the writing of this thesis. I cannot have imagined having better mentors and role models. I also have to thank the staff at the CGR for their role in the sequencing aspects of this thesis. My further thanks extend to the CGR bioinformatics team, most notably Richard, Matthew, Sam and Luca, for not only tolerating the number of bioinformatics questions I have asked them, but also providing great friendship and warmth in the office. I must also give a special mention to Graham Clark at the London School of Hygiene and Tropical Medicine for sending cultures of Entamoeba and providing general advice, especially around the tRNA arrays. I would also like to thank David Starns, for his efforts troubleshooting the Companion pipeline and to Laura Gardiner for providing advice around all things methylation. My gratitude goes to the members of the many offices I have moved around during my PhD, many of which have become close friends who have got me through many bioinformatics conundrums, lab meltdowns and (some equally challenging) gym sessions. Stef, Jen, Charl and Dave – you guys kept me sane. Further, I must also include Sophie and Grace who have also made it through the past seven years at the University of Liverpool. From the first day of being an undergraduate to the final day of being a PhD student. I’m so grateful I got to navigate the adventures of student life with you both – looks like we all made it out okay in the end, right? On a personal note, I must give my warmest thanks to my family, particularly my parents for encouraging me in everything and making this endeavour possible. To my many sisters for being my personal cheerleaders as I made it to the end of this thesis. To my housemate, Adele, who was an excellent sounding board to probably a few too many rants. To John Newsham, the teacher who got me so interested in biology in the first place. And finally, to Troy for his unwavering support and belief that I could achieve such great things. i Abstract Amoebiasis is the third most common cause of mortality worldwide from a parasitic infection. It affects up to 50 million people annually, of whom 100,000 will die from the disease each year. Amoebiasis is caused by the amoeba Entamoeba histolytica, an obligate parasite of humans. Our understanding of the biology of this pathogen has been greatly advanced by the sequencing of its genome. However, the unusual nature of the genome (an extreme nucleotide composition bias, abundant repetitive elements and unknown chromosome structures/ploidy) made it particularly challenging to sequence and the resulting reference genome assembly is highly fragmented and possibly incomplete, limiting its usefulness for some analyses. New sequencing technologies can overcome some of the problems of the previous genome assembly. Here, single molecule real time (SMRT) sequencing was applied to sequence long fragments of DNA and build an improved reference genome for E. histolytica. This thesis describes the generation of sequence data and a comprehensive comparative analysis of genome assembly tools available for long-read SMRT sequencing data. This analysis showed that assembly using PacBio data only produced better quality genome assemblies than hybrid assembly approaches utilising both long- and short-read data together. The PacBio genome assembly is significantly better than the published reference genome assembly based on a range of quality metrics. The new genome assembly was annotated, revealing an increase in gene number. The spatial organisation of key virulence gene families (AIG1, Ariel-1, BspA, cysteine proteases, Gal/GalNAc lectins and STIRP families) was analysed, revealing an association of virulence gene families with transposable elements. The new assembly allowed analyses of two key, unusual features of the E. histolytica genome: the long arrays of multiple tRNA genes and the multi-copy, extra-chromosomal molecules containing the ribosomal DNA. Several lines of evidence were consistent with tRNA arrays capping chromosomes and acting as telomeres in Entamoeba. Variation among array units exists (relevant as they are used as population genetic markers), but the maJority sequence was consistently retrieved when genotyping, suggesting they may be relatively robust markers. Analysis of the rDNA episomes present in the E. histolytica strain sequenced (the HM-1:IMSS strain used for previous whole genome sequencing) revealed that one of the two rDNA episome types described in this strain has apparently been lost during in vitro culture. Genome-wide 5-methylcytosine methylation profiles for trophozoite stage parasites in culture were determined using bisulphite sequencing for the new E. histolytica genome assembly and two additional species (Entamoeba moshkovskii and Entamoeba invadens). The analyses confirmed previous reports of sparse methylation of the genome as a whole but highlighted interesting patterns of methylation. While there was virtually no methylation of genes, there was extensive methylation of transposable elements and tRNA arrays. These patterns suggest methylation functions to suppress active transposition and may play a role in the structural control of tRNA arrays, again consistent with telomeric role. The work presented here improves our understanding of the structure, content and regulation of the E. histolytica genome and provides a platform for improved future analyses for the Entamoeba research community. ii Table of Contents Acknowledgements ....................................................................................................................... i Abstract ............................................................................................................................................ ii Table of Contents ......................................................................................................................... iii Table of figures ............................................................................................................................. ix Table of tables ............................................................................................................................. xii Abbreviations ............................................................................................................................. xiv Chapter 1 – Introduction ................................................................................................... 1 1.1. Entamoeba phylogeny .......................................................................................................... 1 1.2. Entamoeba histolytica and other important Entamoeba species .......................... 3 1.2.1. The Entamoeba histolytica life cycle ....................................................................................... 4 1.2.2. Pathogenicity and treatment of amoebiasis ....................................................................... 6 1.2.3. Epidemiology of amoebiasis ................................................................................................... 10 1.2.4. Other Entamoeba species relevant to E. histolytica research ................................... 12 1.3. The power of genomics and comparative analyses amongst Entamoeba species ............................................................................................................................................ 13 1.3.1. The Entamoeba histolytica genome ..................................................................................... 14 1.3.2. Genome structure and gene content of the Entamoeba histolytica genome ...... 19 1.3.3. Gene regulation mechanisms in Entamoeba histolytica ............................................. 25 1.3.4. Comparative genomics among Entamoeba species ...................................................... 27 1.4. Improvements to the assembly of repetitive, complex genomes ...................... 28 1.4.1. Single Molecule Real Time (SMRT) sequencing ............................................................. 29 1.4.2. BioNano optical mapping ......................................................................................................... 30 1.5. Gaps still remaining in Entamoeba knowledge ........................................................ 31 1.5.1. Organisation of genes and gene families ........................................................................... 31 1.5.2. Structural features of the E. histolytica genome and associated genes ................ 32 1.5.3. Distribution of DNA methylation across the E. histolytica genome ....................... 33 1.6. Aims of thesis ....................................................................................................................... 34 Chapter 2 – SMRT sequencing and assembly of the Entamoeba histolytica HM-1:IMSS genome ..........................................................................................................
Recommended publications
  • First Report of Entamoeba Moshkovskii in Human Stool Samples From
    Kyany’a et al. Tropical Diseases, Travel Medicine and Vaccines (2019) 5:23 https://doi.org/10.1186/s40794-019-0098-4 SHORT REPORT Open Access First report of Entamoeba moshkovskii in human stool samples from symptomatic and asymptomatic participants in Kenya Cecilia Kyany’a1,2* , Fredrick Eyase1,2, Elizabeth Odundo1, Erick Kipkirui1, Nancy Kipkemoi1, Ronald Kirera1, Cliff Philip1, Janet Ndonye1, Mary Kirui1, Abigael Ombogo1, Margaret Koech1, Wallace Bulimo1 and Christine E. Hulseberg3 Abstract Entamoeba moshkovskii is a member of the Entamoeba complex and a colonizer of the human gut. We used nested polymerase chain reaction (PCR) to differentiate Entamoeba species in stool samples that had previously been screened by microscopy. Forty-six samples were tested, 23 of which had previously been identified as Entamoeba complex positive by microscopy. Of the 46 specimens tested, we identified nine (19.5%) as E. moshkovskii-positive. In seven of these nine E. moshkovskii-positive samples, either E. dispar or E. histolytica (or both) were also identified, suggesting that co-infections may be common. E. moshkovskii was also detected in both symptomatic and asymptomatic participants. To the best of our knowledge, this is the first report of E. moshkovskii in Kenya. Keywords: Entamoeba, Entamoeba moshkovskii, Diarrhea, Kenya, Nested PCR Introduction was isolated from both symptomatic and asymptomatic Entamoeba moshkovskii is a member of the Entamoeba participants [7]. A 2012 study by Shimokawa and collegues complex and is morphologically indistinguishable from E. [11] pointed to the possible pathogenicity of E. moshkovskii dispar and the pathogenic E. histolytica.WHOrecom- as a cause of diarrhea in mice and infants.
    [Show full text]
  • An Unusual Case of Amoebic Liver Abscess Presenting with Hepatic Encephalopathy: a Case Report
    Case Report An Unusual Case of Amoebic Liver Abscess Presenting with Hepatic Encephalopathy: A Case Report Anil Kumar SARDA, Rakesh MITTAL Submitted: 16 Sep 2010 Department of Surgery, Maulana Azad Medical College and Lok Nayak Accepted: 3 Jan 2011 Hospital, New Delhi 110 002, India Abstract Amoebic liver abscess (ALA) with jaundice and encephalopathy is a rare occurrence and has been recognised and studied more frequently in recent years. We present a case of massive ALA presenting with jaundice, hepatic encephalopathy, and septicaemia that was treated successfully with percutaneous drainage of the abscess, right-sided chest tube insertion, and anti-amoebic therapy. Keywords: amoebiasis, hepatic encephalopathy, hepatology, jaundice, liver abscess Introduction On chest examination, there was bilateral equal air entry. Upon investigation, haemoglobin was Amoebic liver abscess (ALA) is the most 11 g/dL, with a total leukocyte count of frequent extra-intestinal manifestation of 13 000 cells/mm3 (normal range is 4000– Entamoeba histolytica infection. It has been 11 000 cells/mm3). Liver function tests revealed reported that jaundice is uncommon and mild total serum bilirubin of 20 mg/dL, with direct in liver abscess, and some even consider the bilirubin of 15 mg/dL, serum glutamic-oxaloacetic presence of jaundice as a feature against the transaminase (SGOT) of 324 IU/L (normal level diagnosis of hepatic amoebiasis (1). The cause of is less than 40 IU/L), serum glutamic–pyruvic jaundice in a case of ALA has been hypothesised transaminase (SGPT) of 340 IU/L (normal level to result from either hepatocellular dysfunction or is less than 40 IU/L), and alkaline phosphatase intrahepatic biliary obstruction (2).
    [Show full text]
  • Entamoeba Histolytica
    Journal of Clinical Microbiology and Biochemical Technology Piotr Nowak1*, Katarzyna Mastalska1 Review Article and Jakub Loster2 1Laboratory of Parasitology, Department of Microbiology, University Hospital in Krakow, 19 Entamoeba Histolytica - Pathogenic Kopernika Street, 31-501 Krakow, Poland 2Department of Infectious Diseases, University Protozoan of the Large Intestine in Hospital in Krakow, 5 Sniadeckich Street, 31-531 Krakow, Poland Humans Dates: Received: 01 December, 2015; Accepted: 29 December, 2015; Published: 30 December, 2015 *Corresponding author: Piotr Nowak, Laboratory of Abstract Parasitology, Department of Microbiology, University Entamoeba histolytica is a cosmopolitan, parasitic protozoan of human large intestine, which is Hospital in Krakow, 19 Kopernika Street, 31- 501 a causative agent of amoebiasis. Amoebiasis manifests with persistent diarrhea containing mucus Krakow, Poland, Tel: +4812/4247587; Fax: +4812/ or blood, accompanied by abdominal pain, flatulence, nausea and fever. In some cases amoebas 4247581; E-mail: may travel through the bloodstream from the intestine to the liver or to other organs, causing multiple www.peertechz.com abscesses. Amoebiasis is a dangerous, parasitic disease and after malaria the second cause of deaths related to parasitic infections worldwide. The highest rate of infections is observed among people living Keywords: Entamoeba histolytica; Entamoeba in or traveling through the tropics. Laboratory diagnosis of amoebiasis is quite difficult, comprising dispar; Entamoeba moshkovskii; Entamoeba of microscopy and methods of molecular biology. Pathogenic species Entamoeba histolytica has to histolytica sensu lato; Entamoeba histolytica sensu be differentiated from other nonpathogenic amoebas of the intestine, so called commensals, that stricto; commensals of the large intestine; amoebiasis very often live in the human large intestine and remain harmless.
    [Show full text]
  • Amebiasis Annual Report 2017
    Amebiasis Annual Report 2017 Amebiasis Amebiasis is no longer a reportable disease in Louisiana. Outbreaks, however, should still be reported. Amebiasis (amoebiasis) is a parasitic infection caused by Entamoeba histolytica or Entamoeba dispar. The parasite is transmitted by the fecal-oral route, either through direct contact with feces or through the consumption of contaminated food or water. Between 80% and 90% of infected individuals develop no symptoms. For symptomatic cases, the incubation period between infection and illness can range from days to weeks. The symptoms are typically gastrointestinal issues, such as diarrhea or stomach pains. It is also possible for the parasite to spread to the liver and cause abscesses. Entamoeba histolytica can be found world-wide, but is more prevalent in tropical regions with poor sanitary conditions. In some areas with extremely adverse conditions, the prevalence can be as high as 50% in the population. There are no recent data on prevalence of amebiasis in the U.S. however, prevalence is estimated to be between 1% and 4% of the population. High risk groups are refugees, recent immigrants, travelers (particularly those who have spent long periods of time in an endemic area), institutionalized people (particularly developmentally or mentally-impaired people), and men who have sex with men. The number of cases reported within Louisiana is usually low. There are typically less than ten cases per year with a few exceptions (Figure 1). Figure 1: Amebiasis cases - Louisiana, 1970-2017 40 35 30 25 20 15 Number of Cases Number 10 5 0 70 72 74 76 78 80 82 84 86 88 90 92 94 96 98 00 02 04 06 08 10 12 14 16 Year Louisiana Office of Public Health – Infectious Disease Epidemiology Section Page 1 of 4 Amebiasis Annual Report 2017 Hospitalization Hospitalization surveillance is based on Louisiana Hospital Inpatient Discharge Data (LaHIDD).
    [Show full text]
  • Surveillance Study of Acute Gastroenteritis Etiologies in Hospitalized Children in South Lebanon (SAGE Study)
    pISSN: 2234-8646 eISSN: 2234-8840 https://doi.org/10.5223/pghn.2018.21.3.176 Pediatr Gastroenterol Hepatol Nutr 2018 July 21(3):176-183 Original Article PGHN Surveillance Study of Acute Gastroenteritis Etiologies in Hospitalized Children in South Lebanon (SAGE study) Ghassan Ghssein, Ali Salami, Lamis Salloum, Pia Chedid*, Wissam H Joumaa, and Hadi Fakih† Rammal Hassan Rammal Research Laboratory, Physio-toxicity (PhyTox) Research Group, Lebanese University, Faculty of Sciences (V), Nabatieh, *Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Balamand, †Department of Pediatrics, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon Purpose: Acute gastroenteritis (AGE) is a major cause of morbidity and remains a major cause of hospitalization. Following the Syrian refugee crisis and insufficient clean water in the region, this study reviews the etiological and epidemiological data in Lebanon. Methods: We prospectively analyzed demographic, clinical and routine laboratory data of 198 children from the age of 1 month to 10 years old who were admitted with the diagnosis of AGE to a private tertiary care hospital located in the district of Nabatieh in south Lebanon. Results: Males had a higher incidence of AGE (57.1%). Pathogens were detected in 57.6% (n=114) of admitted pa- tients, among them single pathogens were found in 51.0% (n=101) of cases that consisted of: Entamoeba histolytica 26.3% (n=52), rotavirus 18.7% (n=37), adenovirus 6.1% (n=12) and mixed co-pathogens found in 6.6% (n=13). Breast-fed children were significantly less prone to rotavirus (p=0.041). Moreover, children who had received the rota- virus vaccine were significantly less prone to rotavirus (p=0.032).
    [Show full text]
  • Amoebic Colitis Presenting As Subacute Intestinal Obstruction with Perforation
    International Journal of TROPICAL DISEASE & Health 41(16): 58-62, 2020; Article no.IJTDH.61831 ISSN: 2278–1005, NLM ID: 101632866 Amoebic Colitis Presenting as Subacute Intestinal Obstruction with Perforation Renuka Verma1, Archana Budhwar1*, Priyanka Rawat1, Niti Dalal1, Anjali Bishlay1 and Sunita Singh1 1Pt. B. D. Sharma Post Graduate Institute of Medical Sciences, Rohtak-124001, Haryana, India. Authors’ contributions This work was carried out in collaboration among all authors. Authors RV and SS designed the study, reviewed the manuscript and edited it. Author Archana Budhwar wrote the protocol and wrote the first draft of the manuscript. Author PR managed the literature searches. Authors ND and Anjali Bishlay managed the analyses of the study. All authors read and approved the final manuscript. Article Information DOI: 10.9734/IJTDH/2020/v41i1630367 Editor(s): (1) Dr. Giuseppe Murdaca, University of Genoa, Italy. Reviewers: (1) Ammar M. Al-Aalim, Mosul University, Iraq. (2) Tarunbir Singh, Guru Angad Dev Veterinary & Animal Sciences University, Ludhiana. Complete Peer review History: http://www.sdiarticle4.com/review-history/61831 Received 10 August 2020 Case Study Accepted 16 October 2020 Published 12 November 2020 ABSTRACT Infestation with Entamoeba histolytica is worldwide, especially in developing areas. Presented case study included amoebic colitis in a 45 years old man complaining of abdominal distension and non- passage of stools since three days. Abdominal region was diffusely distended and tender in right iliac fossa. Plain abdominal radiography revealed prominent gut loops and minimal intergut free fluid. At laparotomy, malrotation of gut was present. Histopathological examination of intestinal samples confirmed final diagnosis of amoebic colitis post-operatively.
    [Show full text]
  • Protozoan Parasites
    Welcome to “PARA-SITE: an interactive multimedia electronic resource dedicated to parasitology”, developed as an educational initiative of the ASP (Australian Society of Parasitology Inc.) and the ARC/NHMRC (Australian Research Council/National Health and Medical Research Council) Research Network for Parasitology. PARA-SITE was designed to provide basic information about parasites causing disease in animals and people. It covers information on: parasite morphology (fundamental to taxonomy); host range (species specificity); site of infection (tissue/organ tropism); parasite pathogenicity (disease potential); modes of transmission (spread of infections); differential diagnosis (detection of infections); and treatment and control (cure and prevention). This website uses the following devices to access information in an interactive multimedia format: PARA-SIGHT life-cycle diagrams and photographs illustrating: > developmental stages > host range > sites of infection > modes of transmission > clinical consequences PARA-CITE textual description presenting: > general overviews for each parasite assemblage > detailed summaries for specific parasite taxa > host-parasite checklists Developed by Professor Peter O’Donoghue, Artwork & design by Lynn Pryor School of Chemistry & Molecular Biosciences The School of Biological Sciences Published by: Faculty of Science, The University of Queensland, Brisbane 4072 Australia [July, 2010] ISBN 978-1-8649999-1-4 http://parasite.org.au/ 1 Foreword In developing this resource, we considered it essential that
    [Show full text]
  • (PCR) in Rural Communities in Malaysia Romano Ngui, Lorainne Angal, Siti Aminah Fakhrurrazi, Yvonne Lim Ai Lian, Lau Yee Ling, Jamaiah Ibrahim and Rohela Mahmud*
    Ngui et al. Parasites & Vectors 2012, 5:187 http://www.parasitesandvectors.com/content/5/1/187 RESEARCH Open Access Differentiating Entamoeba histolytica, Entamoeba dispar and Entamoeba moshkovskii using nested polymerase chain reaction (PCR) in rural communities in Malaysia Romano Ngui, Lorainne Angal, Siti Aminah Fakhrurrazi, Yvonne Lim Ai Lian, Lau Yee Ling, Jamaiah Ibrahim and Rohela Mahmud* Abstract Background: In this study, a total of 426 human faecal samples were examined for the presence of Entamoeba histolytica, Entamoeba dispar, Entamoeba moshkovskii infection via a combination of microscopic examination and nested polymerase chain reaction (PCR) targeting 16S ribosomal RNA of Entamoeba species. Methods: Faecal sample were collected from 426 participants in five rural villages in Peninsular Malaysia. The faecal samples were processed by direct wet smear and formalin ethyl acetate concentration technique followed by iodine staining and examined via microscopy for the presence of Entamoeba species and other intestinal parasites. Microscopically positive samples for Entamoeba species cysts were further characterized using a Nested Polymerase Chain Reaction (Nested-PCR) targeting 16S-like ribosomal RNA gene. The data entry and analysis was carried out using the SPSS software (Statistical Package for the Social Sciences) program for Windows version 17 (SPSS, Chicago, IL, USA). Results: Based on single faecal examination, overall prevalence of Entamoeba infection was 17.6% (75/426). Females (19.1%) were more commonly infected compared to males (15.9%). Comparison by age groups showed that adults (23.9%) had higher infection rates than children (15.3%). The PCR results showed that 52 out of 75 microscopy positive samples successfully generated species-specific amplicons.
    [Show full text]
  • Granulomatous Meningoencephalitis Balamuthia Mandrillaris in Peru: Infection of the Skin and Central Nervous System
    SMGr up Granulomatous Meningoencephalitis Balamuthia mandrillaris in Peru: Infection of the Skin and Central Nervous System A. Martín Cabello-Vílchez MSc, PhD* Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical “Alexander von Humboldt” *Corresponding author: Instituto de Medicina Tropical “Alexander von Humboldt”, Av. Honorio Delgado Nº430, San A. Martín Cabello-Vílchez, Universidad Peruana Cayetano Heredia, MartínPublished de Porras, Date: Lima-Perú, Tel: +511 989767619, Email: [email protected] February 16, 2017 ABSTRACT Balamuthia mandrillaris is an emerging cause of sub acute granulomatous amebic encephalitis (GAE) or Balamuthia mandrillaris amoebic infection (BMAI). It is an emerging pathogen causing skin lesions as well as CNS involvement with a fatal outcome if untreated. The infection has been described more commonly in inmunocompetent individuals, mostly males, many children. All continents have reported the disease, although a majority of cases are seen in North and South America, especially Peru. Balamuthia mandrillaris is a free living amoeba that can be isolated from soil. In published reported cases from North America, most patients will debut with neurological symptoms, where as in countries like Peru, a skin lesion will precede neurological symptoms. The classical cutaneous lesionis a plaque, mostly located on face, knee or other body parts. Diagnosis requires a specialized laboratory and clinical experience. This Amoebic encephalitis may be erroneously interpreted as a cerebral neoplasm, causing delay in the management of the infection. Thediagnosis of this infection has proven to be difficult and is usually made post-mortem but in Peru many cases were pre-morten. Despite case fatality rates as high as > 98%, some experimental therapies have shown protozoal therapy with macrolides and phenothiazines.
    [Show full text]
  • Human Parasitology
    HUMAN PARASITOLOGY FOURTH EDITION BURTON J. BOGITSH,PHD CLINT E. CARTER,PHD THOMAS N. OELTMANN,PHD AMSTERDAM • BOSTON • HEIDELBERG • LONDON NEW YORK • OXFORD • PARIS • SAN DIEGO SAN FRANCISCO • SINGAPORE • SYDNEY • TOKYO Academic Press is an imprint of Elsevier Academic Press is an imprint of Elsevier 225 Wyman Street, Waltham, MA 02451, USA The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, UK Ó 2013 Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval system, without permission in writing from the Publisher. Details on how to seek permission, further information about the Publisher’s permissions policies and our arrangements with organizations such as the Copyright Clearance Center and the Copyright Licensing Agency, can be found at our website: www.elsevier.com/permissions This book and the individual contributions contained in it are protected under copyright by the Publisher (other than as may be noted herein). Notices Knowledge and best practice in this field are constantly changing. As new research and experience broaden our understanding, changes in research methods, professional practices, or medical treatment may become necessary. Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds, or experiments described herein. In using such information or methods they should be mindful of their own safety and the safety of others, including parties for whom they have a professional responsibility. To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors, assume any liability for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein.
    [Show full text]
  • 3-Treatment of Dysentery and Amoebiasis .Pdf
    Treatment of dysentery and amoebiasis Objectives: 1. To understand different causes of dysentery. 2. To describe different classes of drugs used in treatment of both bacillary dysentery and amebic dysentery. 3. To be able to describe actions, side effects of drugs for treating bacillary dysentery. 4. To understand the pharmacokinetics, actions, clinical applications and side effects of antiamebic drugs. 5. to be able to differentiate between types of antiamebic drugs; luminal amebicides, and tissue amebicide. Editing File Color index: Important Note Extra Mind Maps Mnemonics Metronidazole اﻟﻤﯿﺘﻮ ﯾﻤﺸﻲ ﻻﻣﺎﻛﻦ ﺑﻌﯿﺪه ﻓﯿﺼﯿﺮ ﻧﺴﺘﺨﺪم ھﺬا اﻟﺪرق ﻓﻲ( Metro → systemic amoebicides( trophozoites - ﻧﺪى ﻗﺮﯾﯿﯿﺐ ﻣﻦ DNA ﻓﮭﻮ ﯾﺴﻮي اﻧﮭﺒﺖ ﻟﺪي ان اي رﯾﺒﻠﯿﻜﯿﺸﻦ → Nida - ﺟﺎﯾﮫ اﺣﺎول اﺻﯿﺮ طﺒﯿﺒﺔ اﺳﻨﺎن ﺑﺲ ﻗﺎﻟﻮا ﻟﻲ ﺑﻮو ﯾﺎ ﻛﺬاﺑﮫ !Clinical uses : Gia tri pu pseudo - .giardiasis → (ﺟﺎﯾﮫ) Gia - .trichomoniasis → (اﺣﺎول) Tri - طﺒﯿﺒﺔ أﺳﻨﺎن → ﯾﺴﺘﺨﺪم ﻓﻲ اﻟﺪﯾﻨﺘﺎل ﺑﺮاﻛﺘﺲ- .peptic ulcer → (ﺑﻮ) Pu - pseudomembranous colitis → (ﻛﺬاﺑﮫ)Pseudo - ﻧﺪى طﺒﯿﺒﺔ اﺳﻨﺎن طﯿﺐ ؟ : ADRs- ﺣﻄﺖ اﻟﺴﯿﻜﺸﻦ وﺻﺎر اﻟﻔﻢ ﺟﺎااف (dry mouth) ﺛﻢ ﺣﻄﺖ اﻟﺒﻨﺞ وﺻﺎر طﻌﻤﮫ ﻣﻮ ﺣﻠﻮ (metallic taste ) ﻋﺎد ﻧﺪى ﻛﺜﺮت ﺑﻨﺞ وﻛﺎن ﯾﺤﺒﮫ اﻟﻔﻨﻘﻞ ﻟﯿﻦ ﺳﻮى ﻟﻲoral thrush وﺑﻌﺪ ﻣﻦ ﻛﺜﺮة اﻟﺒﻨﺞ داﺧﺖ اﻟﺒﯿﺸﻨﺖ وﺻﺎر ﻋﻨﺪھﺎ neurotoxicological effect وﻟﻼﺳﻒ اﻟﺒﯿﺸﺖ ﺑﻠﻌﺖ ﻧﺺ اﻟﺒﻨﺞ وطﻠﻊ ﻣﻊ اﻟﯿﻮرن (dysuria ) وﻻﻧﮭﺎ اﺧﺬت ﻛﺤﻮل ﻗﺒﻞ ﺗﺮوح ﻟﻠﺪﻛﺘﻮره ﻧﺪى ﺻﺎر ﻓﯿﮫ ﺗﻌﺎرض ﻣﻊ اﻟﺒﻨﺞ اﻟﻠﻲ ﺑﻠﻌﺘﮫ (disulfiram like effect) . Emetine وﺣﺪه ﻣﻮﺻﯿﮫ اﺧﺘﮭﺎ ﺗﺠﯿﺐ ﻟﮭﺎ ﺑﺮوﺗﯿﻦ ﺑﺎر ، طﻮﻟﺖ اﺧﺘﮭﺎ ودﻗﺖ ﻋﻠﯿﮭﺎ ﻗﺎﻟﺖ اﻣﺘﺎ ﺗﺠﯿﻦ طﻮﻟﺘﻲ ؟ (emetine) ﻗﺎﻟﺖ اﺧﺘﮭﺎ ﻣﺎرااح اﺟﻲ وﻣﺎﻓﯿﮫ ﺑﺮوﺗﯿﻦ ﺑﺎر ، ﻓﺎﯾﺸﯿﺴﻮي
    [Show full text]
  • Molecular Epidemiology of Human Intestinal Amoebas in Iran in Amoebas Intestinal Human of Epidemiology Molecular Iranian J Publ Health, Vol
    Iranian J Publ Health, Vol. 41, No.9, Sep 2012, pp.10-17 Review Article Molecular Epidemiology of Human Intestinal Amoebas in Iran * H Hooshyar 1, P Rostamkhani 1, M Rezaian 2 1. Dept. of Parasitology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran 2. Dept. of Medical Mycology & Parasitology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran *Corresponding Author: Tel: +98 361 5550021 Fax: +98 361 5551112 (Received 16 Mar 2012; accepted 12 Jul 2012) Abstract on Tuesday, October 09, 2012 Many microscopic-based epidemiological surveys on the prevalence of human intestinal pathogenic and non- pathogenic protozoa including intestinal amoeba performed in Iran show a high prevalence of human intestinal amoeba in different parts of Iran. Such epidemiological studies on amoebiasis are confusing, mainly due to recently appreciated distinction between the Entamoeba histolytica, E. dispar and E. moshkovskii. Differential diagnosis can be done by some methods such as PCR-based methods, monoclonal antibodies and the analysis of isoenzyme typing, however the molecular study of these protozoa in Iran is low. Based on molecular studies, it seems that E. dispar is predominant species especially in the central and northern areas of Iran and amoebiasis due to E. histolytica is a rare infection in the country. It is suggested that infection with E. moshkovskii may be common among Iranians. Considering the importance of molecular epidemiology of amoeba in Iran and also the current data, the present study reviews the data currently available on the molecular distribution of intestinal human amoeba in Iran. http://journals.tums.ac.ir/ Key words: Amoeba, Entamoeba, Molecular epidemiology, Iran Introduction Downloaded from Cases of transmissions for over 18 different hu- tinal amoeba are considered non-pathogenic and man intestinal protozoa have been reported in rarely cause intestinal disease in humans (3,4).
    [Show full text]